Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1982 4
1983 2
1984 1
1985 1
1986 9
1987 1
1988 5
1989 7
1990 10
1991 14
1992 16
1993 28
1994 26
1995 15
1996 17
1997 22
1998 30
1999 40
2000 32
2001 39
2002 45
2003 46
2004 65
2005 81
2006 102
2007 111
2008 193
2009 196
2010 221
2011 269
2012 263
2013 357
2014 407
2015 476
2016 429
2017 517
2018 500
2019 666
2020 777
2021 948
2022 1165
2023 509

Text availability

Article attribute

Article type

Publication date

Search Results

7,803 results

Results by year

Filters applied: . Clear all The following term was not found in PubMed: Meitong
Page 1
Did you mean meidong zhu (60 results)?
Roxadustat: First Global Approval.
Dhillon S. Dhillon S. Drugs. 2019 Apr;79(5):563-572. doi: 10.1007/s40265-019-01077-1. Drugs. 2019. PMID: 30805897 Review.
Roxadustat (Ai Rui Zhuo() in China) is an orally administered, small molecule hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor that is being developed by FibroGen, in collaboration with Astellas and AstraZeneca, for the treatment of anaemia in patients with dial …
Roxadustat (Ai Rui Zhuo() in China) is an orally administered, small molecule hypoxia-inducible factor (HIF) prolyl hydroxylase inhib …
Retraction.
[No authors listed] [No authors listed] J Cell Physiol. 2022 May;237(5):2600. doi: 10.1002/jcp.30741. Epub 2022 Apr 18. J Cell Physiol. 2022. PMID: 35434811
Retraction: "9za plays cytotoxic and proapoptotic roles and induces cytoprotective autophagy through the PDK1/Akt/mTOR axis in non-small-cell lung cancer," by Rangru Liu, Zhuo Chen, Xinan Yi, Fengying Huang, Gaoyun Hu, Danqi Liu, Xi Li, Honghao Zhou, and Zhaoqian Liu, J Ce …
Retraction: "9za plays cytotoxic and proapoptotic roles and induces cytoprotective autophagy through the PDK1/Akt/mTOR axis in non-small-cel …
Retraction.
[No authors listed] [No authors listed] J Cell Biochem. 2021 Jul;122(7):771. doi: 10.1002/jcb.29930. Epub 2021 Apr 20. J Cell Biochem. 2021. PMID: 33988266
Retraction: "MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1," by Lin Wan, Yanlong Tian, Rui Zhang, Zhuo Peng, Jiangli Sun, and Wanggang Zhang, J Cell Biochem. 2018; 3843-3852: The above article, published o …
Retraction: "MicroRNA-103 confers the resistance to long-treatment of adriamycin to human leukemia cells by regulation of COP1," by Lin Wan, …
Qu-Zhuo-Tong-Bi Decoction Alleviates Gouty Arthritis by Regulating Butyrate-Producing Bacteria in Mice.
Wen X, Lou Y, Song S, He Z, Chen J, Xie Z, Shi X, Wen C, Shao T. Wen X, et al. Front Pharmacol. 2021 Feb 2;11:610556. doi: 10.3389/fphar.2020.610556. eCollection 2020. Front Pharmacol. 2021. PMID: 33603667 Free PMC article.
Qu-zhuo-tong-bi decoction (QZTBD) is a traditional Chinese medicine prescription used to treat hyperuricemia and gout with no obvious adverse effects. ...
Qu-zhuo-tong-bi decoction (QZTBD) is a traditional Chinese medicine prescription used to treat hyperuricemia and gout with no obvious …
Insulinoma.
Zhuo F, Anastasopoulou C. Zhuo F, et al. 2022 Jul 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. 2022 Jul 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 31335019 Free Books & Documents.
In Response.
Zhuo Q, Wang L. Zhuo Q, et al. Anesth Analg. 2022 Oct 1;135(4):e25. doi: 10.1213/ANE.0000000000006151. Epub 2022 Sep 15. Anesth Analg. 2022. PMID: 36108197 No abstract available.
In Response.
Zhuo Q, Wang L. Zhuo Q, et al. Anesth Analg. 2022 Oct 1;135(4):e26-e27. doi: 10.1213/ANE.0000000000006164. Epub 2022 Sep 15. Anesth Analg. 2022. PMID: 36108199 No abstract available.
Descending facilitation.
Zhuo M. Zhuo M. Mol Pain. 2017 Jan;13:1744806917699212. doi: 10.1177/1744806917699212. Mol Pain. 2017. PMID: 28326945 Free PMC article. Review.
7,803 results